Federal Register / Vol. 69, No. 198 / Thursday, October 14, 2004 / Notices 61027

Contact Person: Jennifer E. Gorman Vetter, 

NIH Public Liaison/COPR Coordinator, Office 

of Communications and Public Liaison, 

Office of the Director, National Institutes of 

Health, 9000 Rockville Pike, Building 1, 

Room 344, Bethesda, MD 20892, (301) 435–

4448, gormanj@od.nih.gov.

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s home page: www.nih.gov/

about/publicliaison/index.html, where an 

agenda and any additional information for 

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS)

Dated: October 6, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22989 Filed 10–13–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Board of 

Scientific Advisors. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: National Cancer 

Institute Board of Scientific Advisors. 

Date: November 8–9, 2004. 

Time: November 8, 2004, 8 a.m. to 6 p.m. 

Agenda: Director’s Report; Ongoing and 

New Business; Reports of Program Review 

Group(s); and Budget Presentation; Reports of 

Special Initiatives; RFA and RFP Concept 

Reviews; and Scientific Presentations. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Time: November 9, 2004, 8:30 a.m. to 1 

p.m. 

Agenda: Reports of Special Initiatives; RFA 

and RFP Concept Reviews; and Scientific 

Presentations. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Paulette S. Gray, PhD, 

Executive Secretary, Acting Director, 

Division of Extramural Activities, National 

Cancer Institute, National Institutes of 

Health, 6116 Executive Boulevard, 8th Floor, 

Rm. 8001, Bethesda, MD 20892, 301–496–

5147. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/bsa.htm, where 

an agenda and any additional information for 

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)

Dated: October 6, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22991 Filed 10–13–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Director’s 

Consumer Liaison Group. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: National Cancer 

Institute Director’s Consumer Liaison Group. 

Date: November 4, 2004. 

Time: 3 p.m. to 4:45 p.m. 

Agenda: Report from NCI Listens and 

Learns Operations Working Group/

Discussion; Report from NCI Listens and 

Learns Promotions Working Group/

Discussion; Report from NCI Listens and 

Learns Summit Working Group/Discussion; 

Report from NCI Listens and Learns 

Evaluation Working Group/Discussion; Next 

Steps. 

Place: National Institutes of Health, 

National Cancer Institute, 6116 Executive 

Boulevard, Suite 220, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Nancy Caliman, Executive 

Secretary, Office of Liaison Activities, 

National Institutes of Health, National Cancer 

Institute, 6116 Executive Boulevard, Suite 

220, MSC8324, Bethesda, MD 20892, (301) 

496–0307, calimann@mail.nih.gov.

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/dclg/dclg.htm,

where an agenda and any additional 

information for the meeting will be posted 

when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support, 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)